Avanos officer surrenders 226 shares for tax withholding

Avanos Medical, Inc. Principal Accounting Officer John Joseph Hurley reported a small tax-related share disposition.

Rhea-AI Filing Summary

Avanos Medical, Inc. Principal Accounting Officer John Joseph Hurley reported a small tax-related share disposition. On March 9, 2026, 226 shares of common stock were surrendered at $13.29 per share to cover tax withholding when 647 time-based restricted share units vested. After this tax-withholding disposition, Hurley directly holds 11,381 shares of Avanos common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 226 shares

Exercise Price or Tax Liability 1 txn

Insider Hurley John Joseph

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	226	$13.29	$3K

Holdings After Transaction: Common Stock — 11,381 shares (Direct)

Footnotes (1)

1. F1. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 647 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 7, 2025 and (ii) vested on March 9, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AVNS Principal Accounting Officer John Hurley report?

John Hurley reported a small tax-related share disposition. He surrendered 226 shares of Avanos common stock at $13.29 per share to satisfy tax withholding obligations tied to restricted share units that vested on March 9, 2026.

Was the AVNS Form 4 transaction an open-market sale of shares?

No, the AVNS Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were surrendered back to Avanos Medical to cover taxes owed when 647 time-based restricted share units vested for the executive.

How many Avanos (AVNS) restricted share units vested for John Hurley?

A total of 647 time-based restricted share units vested for John Hurley. Each TRSU is economically equivalent to one share of Avanos common stock, and the vesting triggered related tax withholding obligations settled with 226 surrendered shares.

How many AVNS shares does John Hurley hold after this Form 4 transaction?

After the tax-withholding disposition, John Hurley directly holds 11,381 shares of Avanos common stock. This figure reflects his updated position following the surrender of 226 shares to satisfy tax obligations upon RSU vesting.

What does transaction code "F" signify in the AVNS Form 4 filing?

Transaction code "F" indicates a payment of tax liability by delivering securities. In this AVNS filing, 226 shares were surrendered to Avanos Medical to cover withholding taxes triggered when 647 time-based restricted share units vested for the reporting officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 02:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hurley John Joseph

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

SUITE 100

(Street)

ALPHARETTA GA 30004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		F(1)		226	D	$13.29	11,381	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 647 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 7, 2025 and (ii) vested on March 9, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ John S. Fischer, as attorney-in-fact for John Joseph Hurley	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.